60
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Inhibition of Carbapenem-resistant Klebsiella pneumonia and multi-drug-resistant Acinetobacter baumannii by nanoemulsion of Satureja rechingeri essential oil

, , &
Pages 157-163 | Received 12 Aug 2022, Accepted 28 Jan 2024, Published online: 26 Feb 2024
 

ABSTRACT

Multi-drug resistant bacteria (MDR) such as MDR Acinetobacter baumanii and carbapenem-resistant Klebsiella pneumonia have become a global concern in recent decades. In this study, S. rechingeri essential oil was analyzed by GC and GC-MS. After that, different nanoemulsions were produced and the optimum formulation was chosen. In addition, the antibacterial activity of the optimum formulation was evaluated against some strains of A. baumanii and K. pneumoniae. Results showed that carvacrol was the main compound of the essential oil (81.55%) and C3 nanoemulsion with a particle size of 93.14 ± 3.95 nm was the optimum and stable formulation. The antibacterial activity assessment revealed that the C3 nanoemulsion also had better antibacterial activity than essential oil. The herbal formulation had comparable antibacterial activity in comparison with six assessed antibiotics. Overall, nanoencapsulated essential oil of S. rechingeri is a candidate for producing a new generation of natural antibacterial compounds against MDR pathogens.

Acknowledgments

We thank Dr J. Hadian for providing S. rechingeri plant samples.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.